{"_id":"lw5y5dOBUoWlhyt7n40JnjRvkIEXtecnQ95gA6sNOYInCKO8Xt5qiA","lastupdate":"2025-03-25T00:00:00.000Z","update_date":"2025-03-25T00:00:00.000Z","lastModified":"Mar 26, 2025","active":1,"confidence_score":46,"confidence_score_reason":"sector, tags, invite member, logo, description, homepage, video or image, funding rounds, markets, external profiles, not claimed","urlname":"neurocords","minimal_profile":null,"status":"Acquired","fullstatus":"Acquired by Orgenesis on Mar, 2025","acquired":null,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":null,"name":"Neurocords","oneliner":"Spinal Cord Treatment Technology ","registrar":"515813897","website":"","careerspage":"","founded_month":3,"founded_year":2018,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"0","employees_exact":0,"patent":null,"raised":0,"stage":"Acquired","public_stage":"Acquired","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":null,"about":"Neurocords is developing regenerative therapies for spinal cord injuries. Its focus is on a novel cellular therapy platform aimed at restoring function following spinal cord injuries.","climatetech_description":null,"is_climatetech_relevant":null,"phone":null,"country":null,"address":{"israeli":[{"id":"W0cf6YhR46pTfGqDA4bYvX7SoBajgNPaW68ngtYlKYHZJ0ouM56rZS","city":"Tel Aviv-Yafo","type":null,"address":"HaRakevet St 58, Tel Aviv-Yafo, Israel","placeid":"ChIJp6X-2mRLHRUR9ncvYW3zwYg","notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"urJn2XuTjTwlikPI3soJRFm7FFx7nhOuLFFYJREWiVclo1lOkK0Q3w","date":"Mar 7, 2025","link":"https://www.biospace.com/press-releases/orgenesis-inc-announces-acquisition-of-certain-neurocords-llc-assets-strengthening-its-regenerative-medicine-portfolio-with-spinal-cord-injury-therapies","source":"www.biospace.com","visible":1,"analysis":{"tags":"acquisition","round":null,"company":"Orgenesis Inc.","layoffs":null,"summary":"Orgenesis Inc., a global biotech company, announced the acquisition of Neurocords LLCs assets related to regenerative medicine therapies for spinal cord injuries. This strategic acquisition aims to expand access to cost-effective treatments by integrating Neurocords technology with Orgenesiss decentralized cell processing approach. The acquisition involves an equity transaction, with Orgenesis issuing 1,200,000 shares of common stock to Neurocords. Orgenesis plans to leverage its AI-based technology to enhance the production of autologous stem cells, potentially accelerating the development of transformative therapies for spinal cord injuries. The acquisition aligns with Orgenesiss mission to improve healthcare outcomes through innovative cell and gene therapies.","partners":["Neurocords LLC"],"customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["Regenerative Medicine","Spinal Cord Injury","Stem Cells","Neural Regeneration","AI Technology"],"date_of_event":"March 6, 2025","product_stage":"clinical trial","investment_date":null,"acquired_company":"Neurocords LLC","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Acquisition","Partners"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Acquisition  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"BVWf79hdNCtfcEswUnNJq2oshlkQjfcKfWPibOI1YNuXzqp8VNfpeq","news_summary":"Orgenesis Inc. Announces Acquisition of Certain Neurocords LLC Assets, Strengthening its Regenerative Medicine Portfolio with Spinal Cord Injury Therapies","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":1,"techcommunityinvolvement":null,"mediagallery":[],"tags":[],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":[],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":0,"lastfunding":"Undisclosed","totalrounds":0,"fundingstage":"Acquired","totalfunding":"Undisclosed","publicinvestors":0,"lastpublicfunding":null,"totalpublicrounds":0,"totalpublicfunding":0},"team":[],"description_edited":null,"tag_line_edited":null,"sector":null,"sectorverify":null,"biverify":{"id":"c9EsgAuuvwml0IzyIKWmOxLUUF5GjptiIXjHR1tp2gTB0O2GoGTfCd","fullname":"Yanina Wainscheinker"},"biverifydate":"2025-03-26T00:00:00.000Z","crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"Maor Perlov","creator_email":"maor.perlov@sncentral.org","createdate":"2025-03-25T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"ryv5nlDLkvAUBl3rD8lb8EmCs0qpdqXTav20RmUe4h7DoEhwHuh4YF","date":"Mar 2025","amount":"Undisclosed","source":"https://www.biospace.com/press-releases/orgenesis-inc-announces-acquisition-of-certain-neurocords-llc-assets-strengthening-its-regenerative-medicine-portfolio-with-spinal-cord-injury-therapies","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"acquiredcompany_mna":"Orgenesis","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6OiYIIDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/orgenesis","acquiredcompany_mna_logokey":"$POBqiArF96ihTfnx76EC1wAgLEiCw3nsOrDPq0MQz0wdFZZiBTode2","acquiredcompany_mna_urlname":"/company_page/orgenesis","acquiredcompany_mna_homepage":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$POBqiArF96ihTfnx76EC1wAgLEiCw3nsOrDPq0MQz0wdFZZiBTode2","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"QTbllx1dAS5Rqxq809qISfLSciJlVXH94UPBYnkcdfcCy44wsUOBUZ","date":"Mar 2022","amount":"Undisclosed","source":"","eventtype":"ClosingEvent","investment":[],"delistreason":"ceased_to_operate","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"3/2018","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Neurocords","logourl":"/assets/startups-icon.svg","oglogourl":"http://localhost/assets/snc_logo.svg","seoabout":"Neurocords is developing regenerative therapies for spinal cord injuries. Its focus is on a novel cellular therapy platform aimed at restoring function fol...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":0,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology"}]}],"targetCustomer":[],"coreTechnology":[]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[],"targetCustomerClassifications":[],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology"],"coreTechnology":[],"targetCustomer":[]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[{"id":"ryv5nlDLkvAUBl3rD8lb8EmCs0qpdqXTav20RmUe4h7DoEhwHuh4YF","date":"Mar 2025","amount":"Undisclosed","source":"https://www.biospace.com/press-releases/orgenesis-inc-announces-acquisition-of-certain-neurocords-llc-assets-strengthening-its-regenerative-medicine-portfolio-with-spinal-cord-injury-therapies","mnatype":"Acquisition","eventtype":"MNAEvent","investment":[],"wasacquired":1,"eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"acquiredcompany_mna":"Orgenesis","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6OiYIIDA","acquiredcompany_mna_type":"Startup","acquiredcompany_mna_hidden":false,"acquiredcompany_mna_fullurl":"/company_page/orgenesis","acquiredcompany_mna_logokey":"$POBqiArF96ihTfnx76EC1wAgLEiCw3nsOrDPq0MQz0wdFZZiBTode2","acquiredcompany_mna_urlname":"/company_page/orgenesis","acquiredcompany_mna_homepage":"","style":"","hiddenCompanyTooltip":"","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$POBqiArF96ihTfnx76EC1wAgLEiCw3nsOrDPq0MQz0wdFZZiBTode2","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","exit_label":"EXIT","po_label":"Initial Public Offering","acquireddesc":"Was acquired by","sectionname":"Public Offerings & Exit","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}